EP3397756
IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
:
EP einkaleyfi: Þýðing ekki lögð inn:
30.12.2016:
8.3.2023:
16881286.5
:
29.12.2036
:
IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
30.12.2016
8.3.2023
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
The Trustees of The University of Pennsylvania:
3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, US
:
MOTZ, Gregory:
Quincy Massachusetts 02170, US
:
MAVRAKIAS, Konstantinos John:
Cambridge Massachusetts 02139, US
:
LIU, Jinbiao:
Shanghai 201203, CN
:
LIU, Lei:
Shanghai 201203, CN
:
ZHENG, Qiangang:
Shanghai 201318, CN
:
XUN, Guoliang:
Shanghai 201203, CN
:
XIAO, Qitao:
Shanghai 201203, CN
:
PCT/CN2015/099882:
30.12.2015:
WO
:
CN2016113612:
30.12.2016
:
C12N 5/0783, C12N 15/113, C07D 295/00, C07D 401/14, A61K 35/17, C07D 207/34, C07K 16/24, C07K 16/28, C07K 16/30, A61P 35/00